Skip to main content
Peptide Intel Hub laboratory research video
Peptide Intel Hub

Research brief · Regenerative

KPV

α-MSH tripeptide fragment studied in mucosal inflammation models.

Class

α-MSH C-terminal tripeptide

Half-life

Short

Studied in

Mucosal and inflammatory bowel models.

What it is

KPV is the C-terminal tripeptide of α-MSH and retains a portion of its anti-inflammatory activity via the melanocortin pathway, with research focus on mucosal models.

Mechanism studied

Anti-inflammatory action via melanocortin pathway.

Research notes

  • Most data derives from rodent IBD-like models.

Before sourcing any material

  • Confirm a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity).
  • Check the stated peptide content per vial, not just the gross vial mass.
  • Plan reconstitution volumes first so the vial size matches your protocol.
  • Verify what is lawful in your jurisdiction — these are in-vitro research reagents, not medicines.
Regenerative research hubAll research briefsLatest research articles
Share
© 2026 Peptide Intel Hub · Marbella · Educational research reference · For in-vitro research use only
Independent publication — we sell nothing. Supplier disclosure

Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.